Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.38% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
EXEL · Oct 2, 2026
EXELIXIS, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0000939767-26-000116General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
42.50% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
10.20% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
4.53% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
96.02% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
40.75% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
31.80% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
4.36% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History2 statesHistory building
Period transition
What moved in the state?
- Previous
- 1.08%
- Current
- 0.38%
- Delta
- -0.71%
- Previous
- 48.95%
- Current
- 42.50%
- Delta
- -6.45%
- Previous
- 10.63%
- Current
- 10.20%
- Delta
- -0.44%
- Previous
- 4.57%
- Current
- 4.53%
- Delta
- -0.03%
- Previous
- 96.71%
- Current
- 96.02%
- Delta
- -0.70%
- Previous
- 39.51%
- Current
- 40.75%
- Delta
- 1.24%
- Previous
- 33.72%
- Current
- 31.80%
- Delta
- -1.92%
- Previous
- 5.18%
- Current
- 4.36%
- Delta
- -0.82%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · Biological Products, (No Diagnostic Substances) peers →Derived From · EXEL Company Quality Vector →Has State · EXELIXIS, INC. →Transitioned To · EXEL CAPEX_INTENSITY_DECREASED →Transitioned To · EXEL CASH_GENERATION_DECREASED →Transitioned To · EXEL GROWTH_DECREASED →Transitioned To · EXEL INVENTORY_PRESSURE_DECREASED →Transitioned To · EXEL MARGIN_DECREASED →Transitioned To · EXEL PROFITABILITY_INCREASED →Transitioned To · EXEL R_AND_D_INTENSITY_DECREASED →Transitioned To · EXEL SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.